HK1041434A1 - Combination of hepatitis b vaccine with antiviral agents - Google Patents

Combination of hepatitis b vaccine with antiviral agents

Info

Publication number
HK1041434A1
HK1041434A1 HK02101211.9A HK02101211A HK1041434A1 HK 1041434 A1 HK1041434 A1 HK 1041434A1 HK 02101211 A HK02101211 A HK 02101211A HK 1041434 A1 HK1041434 A1 HK 1041434A1
Authority
HK
Hong Kong
Prior art keywords
vaccine
hepatitis
combination
antiviral agents
antiviral
Prior art date
Application number
HK02101211.9A
Other languages
Chinese (zh)
Inventor
F Atkinson Gillian
J Boon R
g vandepapeliere P
A C Wettendorff M
Original Assignee
Smithkline Beecham Biologicals S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biologicals S A filed Critical Smithkline Beecham Biologicals S A
Publication of HK1041434A1 publication Critical patent/HK1041434A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
HK02101211.9A 1999-01-12 2002-02-19 Combination of hepatitis b vaccine with antiviral agents HK1041434A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9900630 1999-01-12
PCT/EP1999/010295 WO2000041463A2 (en) 1999-01-12 1999-12-21 Combination of hepatitis b vaccine with antiviral agents

Publications (1)

Publication Number Publication Date
HK1041434A1 true HK1041434A1 (en) 2002-07-12

Family

ID=10845878

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02101211.9A HK1041434A1 (en) 1999-01-12 2002-02-19 Combination of hepatitis b vaccine with antiviral agents

Country Status (19)

Country Link
EP (1) EP1140163A2 (en)
JP (1) JP2002534438A (en)
KR (1) KR20010090011A (en)
CN (1) CN1391482A (en)
AR (1) AR022250A1 (en)
AU (1) AU760574B2 (en)
BR (1) BR9916893A (en)
CA (1) CA2359110A1 (en)
CO (1) CO5241355A1 (en)
CZ (1) CZ20012544A3 (en)
HK (1) HK1041434A1 (en)
HU (1) HUP0105070A2 (en)
IL (1) IL144186A0 (en)
NO (1) NO20013337L (en)
NZ (1) NZ512890A (en)
PL (1) PL349347A1 (en)
TR (1) TR200102024T2 (en)
WO (1) WO2000041463A2 (en)
ZA (1) ZA200105690B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1733735B1 (en) 1998-05-22 2017-03-22 Ottawa Hospital Research Institute Methods and products for inducing mucosal immunity
CA2337743C (en) 1998-07-31 2015-07-07 Yoshihiro Oka Tumor antigen based on products of the tumor suppressor gene wt1
ES2298353T3 (en) 2001-03-22 2008-05-16 International Institute Of Cancer Immunology, Inc. MODIFIED WT1 PEPTIDE.
EP1447092A4 (en) * 2001-09-28 2007-07-11 Haruo Sugiyama Methods of inducing antigen-specific t cells
US8735357B2 (en) 2001-09-28 2014-05-27 International Institute Of Cancer Immunology, Inc. Method of inducing antigen-specific T cells
TWI275392B (en) * 2002-04-08 2007-03-11 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
ZA200503511B (en) 2002-10-29 2006-10-25 Coley Pharmaceutical Group Ltd Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
US7956043B2 (en) 2002-12-11 2011-06-07 Coley Pharmaceutical Group, Inc. 5′ CpG nucleic acids and methods of use
CN100443117C (en) * 2003-05-13 2008-12-17 深圳康泰生物制品股份有限公司 Hepatitis B treating vaccine prepn and its prepn process and use
US8541167B2 (en) 2004-06-03 2013-09-24 Saint Louis University Methods and compositions for vaccination
WO2008104133A1 (en) * 2007-02-28 2008-09-04 Centro De Ingeniería Genética Y Biotecnología Combination therapy for the treatment of chronic hepatitis b
US20220088188A1 (en) * 2018-12-24 2022-03-24 Grand Theravac Life Science (Nanjing) Co., Ltd. Pharmaceutical preparation for treating hepatitis b, preparation method therefor and use thereof
CN117120088A (en) * 2021-04-07 2023-11-24 电化株式会社 Adjuvant activity enhancer and adjuvant composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0414374B1 (en) * 1989-07-25 1997-10-08 Smithkline Biologicals S.A. Novel antigens and methods for their preparation
BR9908599A (en) * 1998-03-09 2000-11-14 Smithkline Beecham Biolog Combined vaccine compositions

Also Published As

Publication number Publication date
BR9916893A (en) 2001-11-20
CO5241355A1 (en) 2003-01-31
CN1391482A (en) 2003-01-15
CZ20012544A3 (en) 2002-01-16
WO2000041463A3 (en) 2000-11-09
NZ512890A (en) 2003-09-26
AR022250A1 (en) 2002-09-04
NO20013337L (en) 2001-08-17
KR20010090011A (en) 2001-10-17
CA2359110A1 (en) 2000-07-20
AU2100900A (en) 2000-08-01
AU760574B2 (en) 2003-05-15
WO2000041463A2 (en) 2000-07-20
IL144186A0 (en) 2002-05-23
EP1140163A2 (en) 2001-10-10
ZA200105690B (en) 2002-09-25
PL349347A1 (en) 2002-07-15
JP2002534438A (en) 2002-10-15
TR200102024T2 (en) 2001-12-21
NO20013337D0 (en) 2001-07-05
HUP0105070A2 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
IL144171A0 (en) Quinolinecarboxamides as antiviral agents
EP1187827A4 (en) Antiviral agents
HK1052878A1 (en) Ribavirin-pegylated interferon alfa hcv combination therapy
IL145045A0 (en) Vaccine
IL188686A0 (en) Vaccine
HK1039278B (en) Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
HK1041434A1 (en) Combination of hepatitis b vaccine with antiviral agents
GB9826069D0 (en) HIV vaccine
GB9906815D0 (en) Anti-neoplastic viral agents
IL162236A0 (en) Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use
EP1169452A4 (en) Viral variants
GB9915204D0 (en) Vaccine
IL139269A0 (en) Hepatitis vaccine
GB9906437D0 (en) Vaccine
EP1290230A4 (en) Hepatitis c virus conjugates
GB9913327D0 (en) Vaccine
GB9925432D0 (en) Virus preparation
AP2001002076A0 (en) Hiv vaccine
GB9927353D0 (en) Virus preparation and use
GB9928165D0 (en) Baby sling
GB9917981D0 (en) Viral vaccine
GB0012497D0 (en) Antiviral therapy
GB9912883D0 (en) Baby bath
GB9909072D0 (en) Vaccine
GB0012966D0 (en) Anti-neoplastic viral agents